HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

188Re- N,N- bis(2- mercaptoethyl)- N',N'- diethylethylenediamine

Also Known As:

186Re-BMEDA; 186Re-N,N-bis(2-mercaptoethyl)-N',N'-diethylethylenediamine; 188Re-BMEDA

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Polyamines: 3918
    - Diamines: 518
      - Ethylenediamines: 7
        188Re-N,N-bis(2-mercaptoethyl)-N',N'-diethylethylenediamine: 1
- Organometallic Compounds: 64
  - 188Re-N,N-bis(2-mercaptoethyl)-N',N'-diethylethylenediamine: 1

Experts

1.	Chang, Chih-Hsien: 1 article (07/2007)
2.	Chang, Tsui-Jung: 1 article (07/2007)
3.	Chang, Ya-Jen: 1 article (07/2007)
4.	Chen, Liang-Cheng: 1 article (07/2007)
5.	Jan, Meei-Lin: 1 article (07/2007)
6.	Lee, Te-Wei: 1 article (07/2007)
7.	Luo, Tsai-Yueh: 1 article (07/2007)
8.	Ting, Gann: 1 article (07/2007)
9.	Yu, Chia-Yu: 1 article (07/2007)

Related Diseases

1.	Neoplasms (Cancer) 07/01/2007 - "For the biodistribution study, the highest uptake of liposome in tumors was 3.62% +/- 0.73% at 24 h after RBLPL administration, and the tumor to muscle ratio of RBLPL was 7.1-fold higher than that of 188Re-BMEDA. "

Related Drugs and Biologics

1.	Liposomes (Liposome)